HK:9926 Stock Latest News
Company AnnouncementsAkeso Trustee Purchases Approximately 200,000 Shares1d ago
Company AnnouncementsAkeso Announces Trustee Purchase of 200,000 Shares2d ago
Company AnnouncementsAkeso Proposes Additional On-Market Share Purchases3d ago
Company AnnouncementsAkeso Trustee Purchases 336,000 Shares for Approximately HK$21 Million4d ago
Company AnnouncementsAkeso Says Ivonescimab FDA Letter Might Have Caused Share Movements4d agoCompany AnnouncementsAkeso’s Ivonescimab Delivers Phase III Survival Gains in Biliary Tract Cancer3w ago
Company AnnouncementsAkeso Raises HK$1.94 Billion Through Institutional Share Placing1M ago
Company AnnouncementsAkeso to Raise HK$1.94 Billion via Discounted Share Placing1M ago
Company AnnouncementsAkeso’s AK129 Trial Completion Signals Next Step in Immunotherapy Pipeline1M ago9926Company AnnouncementsAkeso’s New AK157D1 Trial Signals Fresh Oncology Upside for Investors1M ago9926
Company AnnouncementsAkeso’s Phase 3 Gastric Cancer Trial Pits Cadonilimab Against Nivolumab-Based Care1M ago9926
Company AnnouncementsAkeso’s Ivonescimab Tops Pembrolizumab in Key Lung Cancer Survival Trial2M ago
Company AnnouncementsAkeso Narrows Interim Loss as Revenue Jumps Nearly 28%2M ago
Company AnnouncementsAkeso’s Ivonescimab Delivers Phase III Survival Gain in Biliary Tract Cancer2M ago




